Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy

Documenti analoghi

• Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies
  di: Narang, Neha Chopra, et al.
  Pubblicazione: (2017)
• Serum ferritin <70 μg/L predicts functional iron deficiency in patients with chronic kidney disease
  di: Neha Garg, et al.
  Pubblicazione: (2018-01-01)
• Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome
  di: Narang, Neha Chopra, et al.
  Pubblicazione: (2016)
• Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
  di: Xia, Leiming, et al.
  Pubblicazione: (2015)
• Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
  di: Chhikara, Sunita, et al.
  Pubblicazione: (2018)